Trials / Completed
CompletedNCT01795001
The Molecular Pathogenesis of Late-onset Fuchs' Endothelial Corneal Dystrophy
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 460 (actual)
- Sponsor
- Universitaire Ziekenhuizen KU Leuven · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to gain further insights into the molecular pathogenesis of Fuchs' endothelial corneal dystrophy (FECD), to identify targets for potential specific drug therapy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | No intervention |
Timeline
- Start date
- 2012-10-01
- Primary completion
- 2017-09-13
- Completion
- 2017-09-13
- First posted
- 2013-02-20
- Last updated
- 2018-05-24
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT01795001. Inclusion in this directory is not an endorsement.